Features

GW Pharma's Guy sells to Whittle

A round-up of the biggest director buys today so far.

Geoffrey Guy, executive chairman of GW Pharmaceuticals, has sold almost £600,000 of shares in the cannabis-based medicine firm to co-founder Brian Whittle.

The purchase of 750,000 shares from Guy at 79p each cost Whittle, who retired as a director at GW last year, £592,500.

Whittle and Guy set up the company in 1998 and listed it on the London Stock Exchange in June 2001.

Guy also gifted, for nil consideration, a further 782,111 shares to Whittle and members of Whittle's family.

Despite transferring over 1.5m shares, or 1.3% of the business, Guy still owns a 15.2% stake.

GW posted a maiden annual profit last month. It made £4m on revenue up to £16.1m from £5.7m thanks to increased sales and milestone revenue from Almirall and Sativax

Top Director Buys

Value: £129,366

Value: £53,480

Value: £35,340

Value: £24,878

Value: £24,878

Value: £22,825

Value: £19,902

Value: £11,750

Value: £11,600

Value: £10,536

Top Director Sells

Value: £592,500

Most Popular

How will we repay our vast debt pile? Do we even need to?
Sponsored

How will we repay our vast debt pile? Do we even need to?

In his recent articles looking at different aspects of the fixed-income investing world, David Stevenson looked at inflation. Today he looks at a clos…
19 Oct 2020
Buying bitcoin could be the best way to play the remote working boom
Bitcoin

Buying bitcoin could be the best way to play the remote working boom

The coronavirus pandemic has accelerated the move to home working, flexible employment practices and the rise of the “digital nomad”. One of the best …
21 Oct 2020
Negative interest rates and the end of free bank accounts
Bank accounts

Negative interest rates and the end of free bank accounts

Negative interest rates are likely to mean the introduction of fees for current accounts and other banking products. But that might make the UK bankin…
19 Oct 2020